Aptose Biosciences and CrystalGenomics Announce Issuance of Australian Patent for CG-806


You May Also Like

MacroGenics Highlights Progress at 2016 R&D Day

Advancement of HER2 franchise led by margetuximabExpansion and progression of B7-H3 franchiseIntroduction of PD-1 ...

Shire plc : Director Declaration

Director Declaration May 22, 2018 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the "Company") ...